Table 3 Comparison of postoperative parameters between HA and non-HA groups
Parameters | HA(n = 61) | non-HA(n = 102) | P value a |
|---|---|---|---|
EPPH | 3 | 2 | 0.360 |
EPPH treatment | 1.000 | ||
Non-surgical therapy | 2 | 1 | |
Reoperation | 1 | 1 | |
LPPH | 4 | 5 | 0.729 |
LPPH treatment | |||
Conservation | 1 | 3 | 0.539 |
Intervention | 1 | 1 | |
Surgery | 2 | 1 | |
POPF | 12 | 18 | 0.747 |
POPF grade | 0.076b | ||
A | 6 | 14 | |
B | 2 | 3 | |
C | 4 | 1 | |
Biliary fistula | 1 | 4 | 0.651 |
DGE Grade C | 2 | 3 | 1.000 |
Hyperbilirubinemia | 4 | 6 | 1.000 |
Infection complications | 20 | 29 | 0.557 c |
Infection site | |||
Incision | 15 | 15 | 0.079 c |
Lung | 1 | 0 | |
Intra-abdominal | 4 | 14 | |
Ascites | 26 | 35 | 0.289c |
Ascites severity | |||
Mild | 14 | 25 | 0.157c |
Middle | 12 | 10 | |
Postoperative delirium | 3 | 1 | 0.148 |
Cardiovascular events | 1 | 0 | 0.374 |
Liver dysfunction | 2 | 0 | 0.139 |
Upper gastrointestinal hemorrhage | 5 | 5 | 0.503 |
Lower gastrointestinal hemorrhage | 1 | 0 | 0.374 |
Multiorgan dysfunction | 2 | 1 | 0.557 |
Clavien-Dindo classification | 0.020b | ||
0 | 28 | 61 | |
I | 11 | 25 | |
II | 12 | 6 | |
IIIa | 2 | 5 | |
IIIb | 2 | 4 | |
IVa | 2 | 0 | |
IVb | 0 | 0 | |
V | 4 | 1 | |
Reoperation | 2 | 4 | 1.000 |
Postoperative ALB infusion dosage(g) * | 169.0 ± 126.1 | 115.6 ± 87.9 | 0.186 d |
Postoperative ALB infusion frequency* | 10.7 ± 6.9 | 5.81 ± 4.0 | 0.365d |
Somatostatin application (day) * | 9.3 ± 4.2 | 10.1 ± 3.8 | 0.215 d |
Postoperative pRBC transfusion(U) * | 4.3 ± 3.1 | 4.0 ± 1.9 | 0.003 d |
Postoperative plasma transfusion (ml) * | 869.0 ± 633.8 | 545.9 ± 373.1 | 0.086 d |
Hospital stay (days) * | 30.0 ± 13.6 | 29.2 ± 13.4 | 0.658 d |
30-day Mortality | 2 | 1 | 0.557 |
60-day Mortality | 4 | 1 | 0.066 |